Inhibition of vein graft intimal and medial thickening by periadventitial application of a sulfated carbohydrate polymer

Journal of Vascular Surgery

Volumn 23, Issue 4, 1996, Pages 650-656

  Toes, G J ^a   Barnathan, E S ^a   Liu, H ^a   Raghunath, P N ^a   Tomaszewski, J E ^a   Caron, R J ^a   Weisz, P B ^a   Van Oeveren, W ^a   Golden, M A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; BROXURIDINE; FIBROBLAST GROWTH FACTOR; POLYMER;

ADVENTITIA; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VEIN GRAFT;

EID: 0029985386     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(96)80046-2     Document Type: Article

References (31)

1. Cox JL Chiasson DA Gotlieb AI Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries Prog Cardiovasc Dis 34 1991 45 68
2. Kockx MM Cambier BA Bortier HE De Meyer GR Van Cauwelaert PA The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts Virchows Arch A Pathol Anat Histopathol 420 1992 155 162
3. Reidy MA Factors controlling smooth-muscle cell proliferation Arch Pathol Lab Med 116 1992 1276 1280
4. Ross R The pathogenesis of atherosclerosis—an update N Engl J Med 314 1986 488 500
5. Bull DA Hunter GC Putnam CW Growth factors and the arterial wall: implications for vessel repair, atherosclerosis and intimal hyperplasia Perspect Vasc Surg 4 1991 89 103
6. Adoock GD Implantation injury J Vasc Surg 10 1989 587 589
7. Clowes AW Karnovsky MJ Suppression by heparin of smooth muscle cell proliferation in injured arteries Nature 265 1977 625 626
8. Clowes AW Clowes MM Kinetics of cellular proliferation after arterial injury—IV: heparin inhibits rat smooth muscle mitogenesis and migration Circ Res 58 1986 839 845
9. Edelman ER Karnovsky MJ Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis Circulation 89 1994 770 776
10. Casteliot JJ Jr Choay J Lormeau JC Petitou M Sache E Karnovsky MJ Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells—II: evidence for a pentasaccharide sequence that contains a 3-O-sulfate group J Cell Biol 102 1986 1979 1984
11. Edelman ER Adams DH Karnovsky MJ Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury Proc Natl Acad Sci U S A 87 1990 3773 3777
12. Bachinsky WB Barnathan ES Liu H Sustained inhibition of intimal thickening: in vitro and in vivo effects of polymeric β-cyclodextrin sulfate J Clin Invest 96 1995 2583 2592
13. Campana D Coustan-Smith E Janossy G Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells J Immunol Methods 107 1988 79 88
14. Zwolak RM Adams MC Clowes AW Kinetics of vein graft hyperplasia: association with tangential stress J Vasc Surg 5 1987 126 136
15. Schwartz LB Pence JC Kerns BJ Ingehart JD McCann RL Hagen PO Kinetics of vein graft cell division and function Surg Forum 47 1991 362 365
16. Makhoul RG Davis WS McCann RL Hagen PO Heparin decreases intimal hyperplasia in experimental vein bypass grafts Circulation 74 1986 11 26
17. Burgess WH Maciag T The heparin-binding (fibroblast) growth factor family of proteins Ann Rev Biochem 58 1989 575 606
18. Herrmann HC Okada S Hozakowska E Inhibition of smooth muscle cell proliferation and experimental angioplasty restenosis by β-cyclodextrin tetradecasulfate Arterioscler Thromb 13 1993 924 931
19. Okada SS Muttreja M Hozakowska E Kuo A Weisz PB Barnathan ES Inhibition of human vascular smooth muscle cell migration and proliferation by β-cyclodextrin tetradecasulfate J Pharmacol Exp Ther 273 1995 948 954
20. Kohler TR Kirkman T Clowes AW Effect of heparin on adaptation of vein grafts to arterial circulation Arteriosclerosis 9 1989 523 528
21. Norman PE House AK Heparin reduces the intimal hyperplasia seen in microvascular vein grafts Aust N Z J Surg 61 1991 942 948
22. Cambria RP Lvarsson BL Fallon JT Abbott WM Heparin fails to suppress intimal proliferation in experimental vein grafts Surgery 111 1992 424 429
23. el-Sanadiki MN Cross KS Murray JJ Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment Ann Surg 212 1990 87 96
24. Calcagno D Conte JV Howell MH Foegh ML Peptide inhibition of neointimal hyperplasia in vein grafts J Vasc Surg 13 1991 475 479
25. O'Donohoe MK Schwartz LB Radic ZS Mikat EM McCann RL Hagen PO Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts Ann Surg 214 1991 727 732
26. Massey MF Davies MG Svendsen E Reduction of experimental vein graft intimal hyperplasia by ketanserin J Surg Res 54 1993 530 538
27. Folkman J Weisz PB Joullie MM Li WW Ewing WR Control of angiogenesis with synthetic heparin substitutes Science 243 1989 1490 1493
28. Weisz PB Kumor K Macarak EJ Protection of erythrocytes against hemolytic agents by cyclodextrin polysulfate Biochem Pharmacol 45 1993 1011 1016
29. Shing Y Folkman J Weisz PB Joullie MM Ewing WR Affinity of fibroblast growth factors for β-cyclodextrin tetradecasulfate Analyt Biochem 185 1990 108 111
30. Raines EW Ross R Purification of human platelet-derived growth factor Methods Enzymol 109 1985 749 773
31. [Review] Ferrara N Houck KA Jakeman LB Winer J Leung DW The vascular endothelial growth factor family of polypeptides J Cell Biochem 47 1991 211 218